FDA Approves Omlyclo (omalizumab-igec), an Interchangeable Biosimilar to Xolair
March 07, 2025 -- Today, the U.S. Food and Drug Administration approved as the first interchangeable biosimilar to Xolair (omalizumab). Omlyclo, like Xolair, is approved to treat the following conditions: Moderate to severe persistent asthma in...
March 07, 2025 -- Today, the U.S. Food and Drug Administration approved as the first interchangeable biosimilar to Xolair (omalizumab).
Omlyclo, like Xolair, is approved to treat the following conditions:
Moderate to severe persistent asthma in...
